United States · FDA National Drug Code directory
Dantrium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42023-123_dd4a56ce-80e3-4794-94a8-cb2b14695b89
- Product NDC
- 42023-123
- Form
- INJECTION
- Composition / generic term
- dantrolene sodium
- Labeler
- Par Health USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090420
- Source listing expiry
- 20271231
Source-listed ingredients
- DANTROLENE SODIUM — 20 mg/60mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 VIAL in 1 CARTON (42023-123-06) / 60 mL in 1 VIAL · 42023-123-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →